Alessandra Pavesio - Feb 11, 2022 Form 4 Insider Report for Bioventus Inc. (BVS)

Role
SVP & Chief Science Officer
Signature
/s/ Anthony D'Adamio, Attorney-in-Fact
Stock symbol
BVS
Transactions as of
Feb 11, 2022
Transactions value $
$0
Form type
4
Date filed
2/15/2022, 08:53 PM
Previous filing
Feb 14, 2022
Next filing
Feb 16, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BVS Class A Common Stock Options Exercise +1.47K +1.24% 120K Feb 11, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BVS Restricted Stock Units Options Exercise $0 -1.47K -100% $0.00* 0 Feb 11, 2022 Class A Common Stock 1.47K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of Class A common stock.
F2 The restricted stock units vested on February 11, 2022.